Defunct Company
Total Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
497
NCT02841540
A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 6, 2016
Completion: Feb 13, 2024
NCT02950922
Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis
Phase: Phase 2
Start: Nov 30, 2016
Completion: Jul 3, 2017
NCT03394677
Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
Start: Jan 25, 2018
Completion: Jul 2, 2018
NCT03415282
Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
Start: Feb 5, 2018
Completion: Aug 7, 2018
NCT04103060
Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo
Start: Sep 27, 2019
Completion: Nov 3, 2020
NCT05981118
Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)
Phase: Phase 2/3
Role: Collaborator
Start: Jul 15, 2024
Completion: Dec 31, 2026
NCT06561321
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
Start: Oct 30, 2024
Completion: Nov 1, 2026